Risques infectieux des nouveaux biologiques immunosuppresseurs : quelles prophylaxies et quand ? [Infectious risks of new immunosuppressive biologicals : which prophylaxis and when ?]
Details
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_598B6C57EC11
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Risques infectieux des nouveaux biologiques immunosuppresseurs : quelles prophylaxies et quand ? [Infectious risks of new immunosuppressive biologicals : which prophylaxis and when ?]
Journal
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
15/04/2020
Peer-reviewed
Oui
Volume
16
Number
690
Pages
724-730
Language
french
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Abstract
Biological treatments are a revolution in the management of many diseases and their development, with the marketing of many new biologics, challenges practitioners in assessing the risk of infectious complications. A rigorous evaluation is required with the introduction of prophylaxis, vaccinations or specific clinical monitoring.
Keywords
Biological Products/adverse effects, Disease Susceptibility, Drug Administration Schedule, Humans, Immunosuppressive Agents/adverse effects, Infections/etiology, Pre-Exposure Prophylaxis/methods
Pubmed
Publisher's website
Open Access
Yes
Create date
25/04/2020 18:52
Last modification date
21/11/2022 8:27
Usage data
